| Save | Compare | ID | Name | Sequence | Length | Level PepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | Mass | Structure | Quality PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | DBs | Primary evidence |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PEPDIA-INT-000378 | Unnamed peptide | WLAHK | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 653.8 Da | Linear | 85 |
| 3 |
| - |
| PEPDIA-INT-001839 | Rubiscolin | YPLDL | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 619.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-010134 | Unnamed peptide | PVPQP | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 536.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-012878 | Unnamed peptide | AKYSY | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 630.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-014966 | Unnamed peptide | VVPPA | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 481.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-018639 | Angiotensin I-converting enzyme inhibitor 14 | TYLGS | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 539.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-019968 | Angiotensin I-converting enzyme inhibitor 7 | IYPRY | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 710.8 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-024501 | Unnamed peptide | HLPLP | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 575.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-025058 | ACE inhibitory peptide | MDFLI | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 637.8 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-027045 | Zein alpha fragment G | IRAQQ | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 614.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-031918 | ACE inhibitory peptide | LVQGS | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 502.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 4 | 1 records1 papers |
| PEPDIA-INT-032518 | Angiotensin I-converting enzyme inhibitor 13 | DYVGN | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 566.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-032525 | Angiotensin I-converting enzyme inhibitor 12 | DIGYY | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 629.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-036682 | Angiotensin I-converting enzyme inhibitor 1, SPP | MLPAY | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 593.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-038159 | Unnamed peptide | VHIPP | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 561.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-044741 | Unnamed peptide | TKVIP | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 556.7 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-048486 | Angiotensin I-converting enzyme inhibitor F7-1 | KDYRL | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 693.8 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-049190 | Unnamed peptide | HPIKH | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 630.8 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-061839 | ACE inhibitory peptide | TVVPG | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 471.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
| PEPDIA-INT-063632 | ACE inhibitory peptide | STYQT | 5 | GoldPepDiana tier derived from the internal quality score plus activity and literature coverage; it is not an external database rating. | 598.6 Da | Linear | 85PepDiana 0–100 composite of sequence, source, activity, literature, and cross-database evidence completeness. | 3 | - |
